Selenitetriglicerydes affect CYP1A1 and QR activity by involvement of reactive oxygen species and Nrf2 transcription factor

Pharmacological Reports

Volumn 62, Issue 2, 2010, Pages 352-361

  Suchocki, Piotr ^a,b   Misiewicz Krzemińska, Irena ^a   Skupińska, Katarzyna ^a   Niedźwiecka, Katarzyna ^b   Lubelska, Katarzyna ^a   Fijałek, Zbigniew ^a,b   Kasprzycka Guttman, Teresa ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Caco 2; Chemoprevention; CYP1A1. cancer cells; Free radicals; Nrf2; Quinone reductase; Selenium; Selol

Indexed keywords

CYTOCHROME P450 1A1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SELENIUM DERIVATIVE; SELOL; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; NFE2L2 PROTEIN, HUMAN; SELENIUM; SODIUM SELENITE; TRIACYLGLYCEROL;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; STRUCTURE ACTIVITY RELATION; ANTAGONISTS AND INHIBITORS; CACO 2 CELL LINE; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS; CACO-2 CELLS; CELL SURVIVAL; CYTOCHROME P-450 CYP1A1; HUMANS; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; REACTIVE OXYGEN SPECIES; SELENIUM; SODIUM SELENITE; TRIGLYCERIDES;

EID: 77953297666     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70275-9     Document Type: Article

References (36)

1. Artursson P, Ungell AL, Löfroth JE: Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments. Pharm Res, 1993, 10, 1123-1129.
2. Bernhard D, Schwaiger W, Crazzolara R, Tinhofer I, Kofler R, Csordas A: Enhanced MTT-reducing activity under growth inhibition by resveratrol in CEM-C7H2 lymphocytic leukemia cells. Cancer Lett, 2003, 195, 193-199.
3. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 1976, 72, 248-254.
4. Brooks JD, Paton VG, Vidanes G: Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol Biomarkers Prev, 2001, 10, 949-954.
5. Bujalska M, Gumułka SW: Effect of selenium compound (selol) on the opioid activity in vincristine induced hyperalgesia. Neuro Endocrinol Lett, 2008, 29, 552-557.
6. Bujalska M, Winecka R, Gumułka SW: Effect of selol on the opioids activity in streptozotocin induced hyperalgesia. Acta Pol Pharm Drug Res, 2008, 65, 691-696.
7. Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T, Mayer RT: Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol, 1985 34, 3337-3345.
8. De Long MJ, Prochaska HJ, Talalay P: Induction of NAD(P)H:quinone reductase in murine hepatoma cells by phenolic antioxidants, azo dyes, and other chemoprotectors: a model system for the study of anticarcinogens. Proc Natl Acad Sci USA, 1986, 83, 787-791.
9. Dinkova-Kostova AT, Holtzlaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M, Talalay P: Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA, 2002, 99, 11908-11913.
10. Drake EN: Cancer chemoprevention: Selenium as a prooxidant, not an antioxidant. Med Hypotheses, 2006, 67, 318-322.
11. El-Shenawy SMA, Hassan NS: Comparative evaluation of the protective effect of selenium and garlic against liver and kidney damage induced by mercury chloride in the rats. Pharmacol Rep, 2008, 60, 199-208.
12. Ghosh J: Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of archidonate 5-lipoxygenase. Biochem Biophys Res Comun, 2004, 315, 624-635.
13. Gonzalez RJ, Tarloff JB: Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activity. Toxicol in Vitro, 2001, 15, 257-259.
14. Hail N Jr, Cortes M, Drake EN, Spallholz JE: Cancer chemoprevention: a radical perspective. Free Radic Biol Med, 2008, 45, 97-110.
15. Healy ZR, Lee NH, Gao X, Goldring MB, Talalay P, Kensler TW, Konstantopoulos K: Divergent responses of chondrocytes and endothelial cells to shear stress: crosstalk among COX-2, the phase 2 response, and apoptosis. Proc Natl Acad Sci USA, 2005,102, 14010-14015.
16. Hiraoka K, Komiya S, Hamada T, Zenmyo M, Inoue A: Osteosarcoma cell apoptosis induced by selenium. J Orthop Res, 2001, 19, 809-814.
17. Jastrzebski Z, Czyzewska-Szafran H, Fijałek Z, Suchocki P, Fitak BA: Toxicity studies of a new selenium Compound, SELOL, in rats. Drugs Exptl Clin Res, 1995, 21, 217-220.
18. Jastrzebski Z, Czyzewska-Szafran H, Remiszewska M, Fijalek Z, Fitak BA, Suchocki P: Effect of administration route on the dynamics of Selol absorption, distribution and elimination. Pol J Environ Stud, 1997, 6, 64-66.
19. Jastrzebski Z, Czyzewska-Szafran H, Remiszewska M, Fijalek Z, Fitak BA, Suchocki P: Pharmacokinetics of Selol, a new agent containing selenium, in rats; Drugs Exptl Clin Res, 1997, 23, 7-11.
20. Kleiner HE, Reed MJ, DiGiovanni J: Naturally occurring coumarins inhibit human cytochromes P450 and block benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene DNA adduct formation in MCF-7 cells. Chem Res Toxicol, 2003, 16, 415-422.
21. Nguyen T, Sherratt PJ, Nioi P, Yang CS, Pickett CB: Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1. J Biol Chem, 2005, 280, 32485-32492.
22. Patent (Pol. PL 176530 (Cl. A61K31/095)).
23. Prochaska HJ, Santamaria AB, Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. Anal Biochem, 1988, 169, 328-336.
24. Qin Y, Lu M, Gong X: Dihydrorhodamine 123 is superior to 2,7-dichlorodihydrofluorescein diacetate and dihydrorhodamine 6G in detecting intracellular hydrogen peroxide in tumor cells. Cell Biol Int, 2008, 32, 224-228.
25. Rushmore TH, Pickett CB: Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants. J Biol Chem, 1980, 265, 14648-14653.
26. Skupinska K, Misiewicz I, Kasprzycka-Guttman T: A comparison of the concentration-effect relationships of PAHs on CYP1A induction in HepG2 and Mcf7 cells. Arch Toxicol, 2007, 81, 183-200.
27. Skupinska K, Misiewicz-Krzeminska I, Lubelska K, Kasprzycka-Guttman T: Sulforaphane and its analogues inhibit CYP1A1 and CYP1A2 activity induced by benzo[a]pyrene. J Biochem Mol Toxicol, 2009, 23, 18-28.
28. Stewart MS, Spallholz JE, Neldner KH, Pence BC: Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med, 1999, 26, 42-48.
29. Suchocki P, Misiewicz I, Skupinska K, Waclawek K, Fijalek Z, Kasprzycka-Guttman T: The activity of Selol in multidrug-resistant and sensitive human leukemia cells. Oncol Rep, 2007, 18, 893-899.
30. Tapiero H, Townsend DM, Tew KD: The antioxidant role of selenium and seleno-compounds. Biomed Pharmacother, 2003, 57, 134-144.
31. van de Kerkhof EG, de Graaf IA, Groothuis GM: In vitro methods to study intestinal drug metabolism. Curr Drug Metab, 2007, 8, 658-675.
32. 2 induces apoptosis with down-regulation of Bcl-2 and upregulation of P53 expression in both immortal human hepatic cell line and hepatoma cell line. Mut Res, 2001, 490, 113-121.
33. Xu C, Li CY, Kong AN: Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res, 2005, 28, 249-268.
34. Yan L, Yee JA, Boylan LM, Spallholz JE: Effect of selenium compounds and thiols on human mammary tumor cells. Biol Trace Elem Res, 1991, 30, 145-162.
35. Zagrodzki P, Bik D, Fitak BA, Suchocki P, Niemczuk K: Selenoenzymes in animal tissues after supplementation with SELOL. Bull Vet Inst Pulawy, 2000, 44, 215-220.
36. Zhang Y, Li J, Tang L: Cancer-preventive isothiocyanates: dichotomous modulators of oxidative stress. Free Radic Biol Med, 2005, 38, 70-77.